ID   MADD4_CAEEL             Reviewed;        1045 AA.
AC   P90884; I2HA89; Q8I4I1;
DT   20-DEC-2017, integrated into UniProtKB/Swiss-Prot.
DT   13-SEP-2004, sequence version 5.
DT   07-APR-2021, entry version 151.
DE   RecName: Full=Protein madd-4 {ECO:0000305};
DE   AltName: Full=Punctin {ECO:0000303|PubMed:24896188};
DE   Flags: Precursor;
GN   Name=madd-4 {ECO:0000312|WormBase:F53B6.2a};
GN   ORFNames=F53B6.2 {ECO:0000312|WormBase:F53B6.2a};
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=6239 {ECO:0000312|Proteomes:UP000001940};
RN   [1] {ECO:0000312|Proteomes:UP000001940}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2 {ECO:0000312|Proteomes:UP000001940};
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for investigating
RT   biology.";
RL   Science 282:2012-2018(1998).
RN   [2] {ECO:0000305}
RP   ALTERNATIVE PROMOTER USAGE (ISOFORMS A AND B), FUNCTION, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, DOMAIN, DISRUPTION
RP   PHENOTYPE, AND MUTAGENESIS OF ARG-398.
RX   PubMed=22014523; DOI=10.1016/j.devcel.2011.07.020;
RA   Seetharaman A., Selman G., Puckrin R., Barbier L., Wong E., D'Souza S.A.,
RA   Roy P.J.;
RT   "MADD-4 is a secreted cue required for midline-oriented guidance in
RT   Caenorhabditis elegans.";
RL   Dev. Cell 21:669-680(2011).
RN   [3] {ECO:0000305}
RP   ALTERNATIVE PROMOTER USAGE (ISOFORMS A AND B), ALTERNATIVE SPLICING
RP   (ISOFORMS A AND C), FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=24896188; DOI=10.1038/nature13313;
RA   Pinan-Lucarre B., Tu H., Pierron M., Cruceyra P.I., Zhan H., Stigloher C.,
RA   Richmond J.E., Bessereau J.L.;
RT   "C. elegans Punctin specifies cholinergic versus GABAergic identity of
RT   postsynaptic domains.";
RL   Nature 511:466-470(2014).
RN   [4] {ECO:0000305}
RP   FUNCTION, AND INTERACTION WITH EVA-1; UNC-40 AND UNC-5.
RX   PubMed=25122090; DOI=10.1371/journal.pgen.1004521;
RA   Chan K.K., Seetharaman A., Bagg R., Selman G., Zhang Y., Kim J., Roy P.J.;
RT   "EVA-1 functions as an UNC-40 Co-receptor to enhance attraction to the
RT   MADD-4 guidance cue in Caenorhabditis elegans.";
RL   PLoS Genet. 10:E1004521-E1004521(2014).
RN   [5] {ECO:0000305}
RP   FUNCTION, INTERACTION WITH NLG-1 AND UNC-40, AND DISRUPTION PHENOTYPE.
RX   PubMed=26028575; DOI=10.1016/j.neuron.2015.05.013;
RA   Tu H., Pinan-Lucarre B., Ji T., Jospin M., Bessereau J.L.;
RT   "C. elegans Punctin Clusters GABA(A) Receptors via Neuroligin Binding and
RT   UNC-40/DCC Recruitment.";
RL   Neuron 86:1407-1419(2015).
RN   [6] {ECO:0000305}
RP   FUNCTION, AND INTERACTION WITH NLG-1 AND NRX-1.
RX   PubMed=26028574; DOI=10.1016/j.neuron.2015.05.015;
RA   Maro G.S., Gao S., Olechwier A.M., Hung W.L., Liu M., Oezkan E., Zhen M.,
RA   Shen K.;
RT   "MADD-4/Punctin and Neurexin Organize C. elegans GABAergic Postsynapses
RT   through Neuroligin.";
RL   Neuron 86:1420-1432(2015).
CC   -!- FUNCTION: Component of an extracellular matrix cue that is involved in
CC       the guidance of dorsoventral midline migrations and in the
CC       specification of postsynaptic domains at neuromuscular junctions (NMJs)
CC       (PubMed:22014523, PubMed:24896188, PubMed:25122090, PubMed:26028575,
CC       PubMed:26028574). Acts as a ligand for the netrin receptor unc-40 and
CC       the neuroligin receptor nlg-1 (PubMed:22014523, PubMed:26028575,
CC       PubMed:25122090, PubMed:24896188). Secreted by the dorsal and ventral
CC       nerve cords to attract sensory axons and muscle membrane extensions
CC       called muscle arms (PubMed:22014523). In parallel with unc-6 and slt-1,
CC       involved in the netrin receptor unc-40 dependent guidance of the AVM
CC       and PVM mechanosensory axons along the dorsal-ventral axis
CC       (PubMed:22014523). The unc-40 coreceptor eva-1 is enhancing the
CC       responsiveness of unc-40 to the madd-4 guidance cue to attract the
CC       muscle arm extensions and AVM mechanosensory axons towards the
CC       dorsoventral midline (PubMed:25122090). Acts as a synaptic organizer
CC       and is required for the specification of inhibitory GABAergic and
CC       excitatory cholinergic identities of postsynaptic domains at
CC       neuromuscular junctions (NMJs) (PubMed:24896188, PubMed:26028575,
CC       PubMed:26028574). Required for the recruitment of unc-40 to both
CC       cholinergic and GABAergic NMJs (PubMed:26028575). Promotes the
CC       clustering of ACh receptors and GABA(A) receptors at postsynaptic sites
CC       during synaptogenesis (PubMed:24896188). The binding to the presynaptic
CC       adhesion protein nrx-1 and to the neuroligin nlg-1 at postsynaptic
CC       sites promotes clustering of GABAergic receptors at postsynaptic NMJs,
CC       thereby contributing to normal GABAergic synaptic transmission
CC       (PubMed:26028574). {ECO:0000269|PubMed:22014523,
CC       ECO:0000269|PubMed:24896188, ECO:0000269|PubMed:25122090,
CC       ECO:0000269|PubMed:26028574, ECO:0000269|PubMed:26028575}.
CC   -!- FUNCTION: Isoform a and isoform c: Promotes the clustering of
CC       acetylcholine receptors (AChR) at excitatory cholinergic synapses of
CC       NMJs via the netrin receptor unc-40. {ECO:0000269|PubMed:24896188}.
CC   -!- FUNCTION: [Isoform b]: Acts as a guidance cue in the attraction of
CC       muscle membrane extensions (muscle arms) to the dorsal cord and in
CC       cooperation with unc-6 to the ventral cord via the netrin receptor unc-
CC       40 and via the unc-40 coreceptor eva-1 (PubMed:22014523,
CC       PubMed:25122090). Together with nrx-1, clusters netrin receptor unc-40
CC       and neuroligin nlg-1 at postsynaptic sites of GABAergic NMJs, thereby
CC       promoting the recruitment of GABA(A) receptors at GABAergic synapses
CC       (PubMed:24896188, PubMed:26028575, PubMed:26028574). Prevents the
CC       recruitment of GABAergic receptors to cholinergic synapses
CC       (PubMed:24896188). {ECO:0000269|PubMed:22014523,
CC       ECO:0000269|PubMed:24896188, ECO:0000269|PubMed:25122090,
CC       ECO:0000269|PubMed:26028574, ECO:0000269|PubMed:26028575}.
CC   -!- SUBUNIT: Interacts with eva-1 (via the SUEL-type lectin domain)
CC       (PubMed:25122090). Interacts with unc-5 (PubMed:25122090). Interacts
CC       with unc-40; the interaction is required for the localization of unc-40
CC       to postsynaptic domains (PubMed:25122090, PubMed:26028575). Isoform a
CC       forms homodimers and heterodimers with isoform b (PubMed:24896188).
CC       Isoform b forms homodimers and heterodimers with isoform a
CC       (PubMed:24896188). Isoform b interacts with nlg-1 (via extracellular
CC       domain); the interaction is required for nlg-1 localization to
CC       postsynaptic domains (PubMed:26028574, PubMed:26028575). Isoform b
CC       interacts (via the Ig-like C2-type domain) with nrx-1 (via C-terminus)
CC       (PubMed:26028574). {ECO:0000269|PubMed:24896188,
CC       ECO:0000269|PubMed:25122090, ECO:0000269|PubMed:26028574,
CC       ECO:0000269|PubMed:26028575}.
CC   -!- SUBCELLULAR LOCATION: Cell projection, axon
CC       {ECO:0000269|PubMed:22014523, ECO:0000269|PubMed:24896188}. Secreted
CC       {ECO:0000269|PubMed:22014523, ECO:0000269|PubMed:24896188}. Cell
CC       junction, synapse {ECO:0000269|PubMed:24896188}. Secreted,
CC       extracellular space, extracellular matrix {ECO:0000269|PubMed:22014523,
CC       ECO:0000269|PubMed:24896188}. Note=Isoform b is secreted by cholinergic
CC       and GABAergic motoneurons and localizes to excitatory cholinergic and
CC       inhibitory GABAergic NMJs, whereas isoform a and isoform c are
CC       exclusively secreted by cholinergic motoneurons and localize to
CC       excitatory cholinergic NMJs. {ECO:0000269|PubMed:22014523,
CC       ECO:0000269|PubMed:24896188}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage, Alternative splicing; Named isoforms=3;
CC       Name=a {ECO:0000312|WormBase:F53B6.2a};
CC         IsoId=P90884-1; Sequence=Displayed;
CC       Name=b {ECO:0000312|WormBase:F53B6.2b};
CC         IsoId=P90884-2; Sequence=VSP_059274;
CC       Name=c {ECO:0000312|WormBase:F53B6.2c};
CC         IsoId=P90884-3; Sequence=VSP_059275;
CC   -!- TISSUE SPECIFICITY: Isoform a: Expressed in the commissural GABAergic
CC       and cholinergic motor neurons in the first larval stage but only in the
CC       cholinergic motor neurons in later larval stages and in adult animals
CC       (PubMed:22014523). At the L1 larval stage, mainly localized at the
CC       nerve ring and at the dorsal cord (PubMed:24896188). Isoform b:
CC       Expressed in the commissural GABAergic and cholinergic motor neurons
CC       whose cell bodies reside in the ventral nerve cord and which extend
CC       axons into the ventral and dorsal nerve cord (PubMed:22014523,
CC       PubMed:24896188). Also expressed in the head neurons RIA, RIC, lateral
CC       IL1s, lateral IL2s, OLLs, RMEs and SABs, all of which extend axons into
CC       the nerve ring (PubMed:22014523, PubMed:24896188). Expressed in the
CC       embryogenic blast cells and the corresponding terminally differentiated
CC       ventral cord motor neurons and head neurons (PubMed:22014523).
CC       {ECO:0000269|PubMed:22014523, ECO:0000269|PubMed:24896188}.
CC   -!- DEVELOPMENTAL STAGE: Isoform a: Expressed in larval stages L1 and L2
CC       and in adult animals. Isoform b: Expressed in embryos, larval stages L1
CC       and L2 and in adult animals. {ECO:0000269|PubMed:22014523}.
CC   -!- DOMAIN: The Ig-like C2-type domain is required for the attraction of
CC       the muscle arm extensions. {ECO:0000269|PubMed:22014523}.
CC   -!- DISRUPTION PHENOTYPE: Disrupts the clustering of the cholinergic
CC       receptor subunits unc-29, unc-38 and acr-16 and the GABAergic receptor
CC       subunit unc-49 at postsynaptic domains of neuromuscular junctions
CC       (NMJs), and the receptors are redistributed to extrasynaptic areas
CC       (PubMed:24896188, PubMed:26028575). Loss of neuroligin receptor nlg-1
CC       and netrin receptor unc-40 localization to NMJs (PubMed:26028575).
CC       Isoform a and isoform c: Defects in AChR localization to cholinergic
CC       synapses (PubMed:24896188). Decreased AChR-dependent currents triggered
CC       by motoneuron stimulation (PubMed:24896188). Isoform b: Extensive
CC       dorsal muscle arm extension defects and weaker ventral muscle arm
CC       extension defects (PubMed:24896188, PubMed:22014523). Relocalization of
CC       GABAergic receptors from GABAergic to cholinergic synapses
CC       (PubMed:24896188, PubMed:26028575). Redistribution of the neuroligin
CC       receptor nlg-1 from GABAergic to cholinergic NMJs (PubMed:26028575). In
CC       a unc-6 mutant background, extensive ventral muscle arm extension
CC       defects (PubMed:22014523). Loss of unc-40 localization at GABAergic
CC       NMJs (PubMed:26028575). {ECO:0000269|PubMed:22014523,
CC       ECO:0000269|PubMed:24896188, ECO:0000269|PubMed:26028575}.
CC   -!- MISCELLANEOUS: [Isoform b]: Produced by alternative promoter usage.
CC       {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform c]: Produced by alternative splicing of isoform
CC       a. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BX284601; CAB03121.3; -; Genomic_DNA.
DR   EMBL; BX284601; CAD56586.1; -; Genomic_DNA.
DR   EMBL; BX284601; CCH63796.1; -; Genomic_DNA.
DR   PIR; T22545; T22545.
DR   RefSeq; NP_001250933.1; NM_001264004.1. [P90884-3]
DR   RefSeq; NP_492405.3; NM_060004.4. [P90884-1]
DR   RefSeq; NP_871884.1; NM_182084.5. [P90884-2]
DR   SMR; P90884; -.
DR   STRING; 6239.F53B6.2a; -.
DR   PaxDb; P90884; -.
DR   EnsemblMetazoa; F53B6.2a.1; F53B6.2a.1; WBGene00009958. [P90884-1]
DR   EnsemblMetazoa; F53B6.2b.1; F53B6.2b.1; WBGene00009958. [P90884-2]
DR   EnsemblMetazoa; F53B6.2c.1; F53B6.2c.1; WBGene00009958. [P90884-3]
DR   GeneID; 172706; -.
DR   KEGG; cel:CELE_F53B6.2; -.
DR   UCSC; F53B6.2b; c. elegans.
DR   CTD; 172706; -.
DR   WormBase; F53B6.2a; CE36859; WBGene00009958; madd-4. [P90884-1]
DR   WormBase; F53B6.2b; CE32429; WBGene00009958; madd-4. [P90884-2]
DR   WormBase; F53B6.2c; CE32428; WBGene00009958; madd-4. [P90884-3]
DR   eggNOG; KOG3538; Eukaryota.
DR   InParanoid; P90884; -.
DR   OMA; STGIHCD; -.
DR   OrthoDB; 38261at2759; -.
DR   PhylomeDB; P90884; -.
DR   Reactome; R-CEL-5173214; O-glycosylation of TSR domain-containing proteins.
DR   PRO; PR:P90884; -.
DR   Proteomes; UP000001940; Chromosome I.
DR   Bgee; WBGene00009958; Expressed in multi-cellular organism and 4 other tissues.
DR   GO; GO:0030424; C:axon; IEA:UniProtKB-SubCell.
DR   GO; GO:0031012; C:extracellular matrix; IBA:GO_Central.
DR   GO; GO:0005615; C:extracellular space; IDA:WormBase.
DR   GO; GO:0045202; C:synapse; IEA:UniProtKB-SubCell.
DR   GO; GO:0004222; F:metalloendopeptidase activity; IBA:GO_Central.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:WormBase.
DR   GO; GO:0033563; P:dorsal/ventral axon guidance; IGI:WormBase.
DR   GO; GO:0030198; P:extracellular matrix organization; IBA:GO_Central.
DR   GO; GO:0050808; P:synapse organization; IMP:WormBase.
DR   Gene3D; 2.20.100.10; -; 9.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR013273; ADAMTS/ADAMTS-like.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR010909; PLAC.
DR   InterPro; IPR000884; TSP1_rpt.
DR   InterPro; IPR036383; TSP1_rpt_sf.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF00090; TSP_1; 1.
DR   PRINTS; PR01857; ADAMTSFAMILY.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SMART; SM00209; TSP1; 9.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF82895; SSF82895; 9.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS50900; PLAC; 1.
DR   PROSITE; PS50092; TSP1; 6.
PE   1: Evidence at protein level;
KW   Alternative promoter usage; Alternative splicing; Cell junction;
KW   Cell projection; Disulfide bond; Extracellular matrix; Glycoprotein;
KW   Immunoglobulin domain; Reference proteome; Repeat; Secreted; Signal;
KW   Synapse.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000255"
FT   CHAIN           24..1045
FT                   /note="Protein madd-4"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_5004161775"
FT   DOMAIN          24..71
FT                   /note="TSP type-1 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DOMAIN          236..292
FT                   /note="TSP type-1 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DOMAIN          294..510
FT                   /note="TSP type-1 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DOMAIN          512..572
FT                   /note="TSP type-1 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DOMAIN          576..635
FT                   /note="TSP type-1 5"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          637..732
FT                   /note="Ig-like C2-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DOMAIN          811..873
FT                   /note="TSP type-1 6"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          932..990
FT                   /note="TSP type-1 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DOMAIN          1004..1041
FT                   /note="PLAC"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00233"
FT   CARBOHYD        268
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        280
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        730
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        781
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        899
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        906
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   DISULFID        35..65
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        39..70
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        50..55
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        674..722
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         1..351
FT                   /note="MKCSYTVVFLLFYLLIASFHVDALSWAAWSPWSSCTKTCGGGVSRQLRRCLT
FT                   SKCSGESVRFKVCAQKTCESKSRLARDTICGGEEIVSRGQCEVVCRSRLTGANFLWRVD
FT                   DGTPCQAATSRAVCSKGSCQIVGCDGLISSSFRFDACGVCGGRGDTCDNGKFIWKVSEE
FT                   YTACASNCDDIVDWSGAGRSIASTSQPIVVCVNAITGRVVPEKLCADKLRPKVEARPCP
FT                   MLICPSRCRWMAADWTECVPHCGEGTRKREVYCVQTAHNVTVHVPDTFCENGTRPAAEE
FT                   NCVSTSCGRWEAGKWSKCTASCGQGVRRRHVACVGGSDCDEGGRPRQETTCYAGIPCSI
FT                   ATNS -> MLPLLLILSAPLGVSAF (in isoform b)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_059274"
FT   VAR_SEQ         237..238
FT                   /note="Missing (in isoform c)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_059275"
FT   MUTAGEN         398
FT                   /note="R->H: Disrupts the attraction of the muscle arm
FT                   extensions."
FT                   /evidence="ECO:0000269|PubMed:22014523"
SQ   SEQUENCE   1045 AA;  116125 MW;  F78269D1D50228B1 CRC64;
     MKCSYTVVFL LFYLLIASFH VDALSWAAWS PWSSCTKTCG GGVSRQLRRC LTSKCSGESV
     RFKVCAQKTC ESKSRLARDT ICGGEEIVSR GQCEVVCRSR LTGANFLWRV DDGTPCQAAT
     SRAVCSKGSC QIVGCDGLIS SSFRFDACGV CGGRGDTCDN GKFIWKVSEE YTACASNCDD
     IVDWSGAGRS IASTSQPIVV CVNAITGRVV PEKLCADKLR PKVEARPCPM LICPSRCRWM
     AADWTECVPH CGEGTRKREV YCVQTAHNVT VHVPDTFCEN GTRPAAEENC VSTSCGRWEA
     GKWSKCTASC GQGVRRRHVA CVGGSDCDEG GRPRQETTCY AGIPCSIATN SLDWNDRAYL
     DGNTFGSMDN HNDWQAPRLV AGEWSTCSST CGTGVMSRTV ECVAVNPISS APIKLPMSEC
     QDQEQPKLFE SCEVRSCPLQ EDSKLSEDEA PYQWRYGDWT QCSASCLGGK QKAALKCIQV
     STGKSVQWSQ CDARRRPPEK SRPCNQHPCP PFWLTSKYSD CSMSCGSGTA RRSVKCAQTV
     SKTDGADAHI VLRDDRCHFK KPQETETCNV VACPATWVTA QWTECSRSCD SGERRRQVWC
     EIRDSRGKTQ RRPDVECDAN TKPQTVEVCS FGSCSRPELL SNRVFEQNAE QKKLTLGIGG
     VATLYQGTSI KIKCPAKKFD KKKIYWKKNG KKIKNDAHIK VSANGNLRVF HARMEDAGVY
     ECFTDRLQGN VTLNFKYRDF PASRVDLAPK PQIPSTKNRQ RVQVSKEDVL REQASVLHKM
     NVSLIEALLT APNDEKAREQ LRKYGNELVA RWDIGHWSEC RQKTCHVAGY QARGISCKVT
     FHGEIRNVDN SICESLASVR PPETRPCHRE DCPRWEASQW SECSSQRCVS SMLAQKRRNV
     TCRFTNGTSV DIQHCDITNR PATTMDCPNQ NCKAEWRTSD WGSCSSECGT GGVQLRLLSC
     VWISSGRPAG RNCEQMRRPH SARACVADEP LPPCMPTASA LYQRDASCQD QSRFCDIIKL
     FHSCDSLEVR QKCCSTCTFV ERKKF
//
